A standard heparin nomogram for the management of heparin therapy.
暂无分享,去创建一个
J. Hirsh | M. Levine | M. Cruickshank | Mark Levine | R. Roberts | M. Siguenza | Moirra K. Cruickshank | Margaret Siguenza
[1] A. Fennerty,et al. Non-biological factors in day to day variation of heparin requirements. , 1989, BMJ.
[2] J. Newman,et al. Physician practices in the treatment of pulmonary embolism and deep venous thrombosis. , 1988, Archives of internal medicine.
[3] G. Raskob,et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. , 1986, The New England journal of medicine.
[4] J. Hirsh,et al. Hemorrhagic Complications of Anticoagulant Therapy , 1986, Seminars in thrombosis and hemostasis.
[5] P. Routledge,et al. Audit of control of heparin treatment. , 1985, British medical journal.
[6] W. Grove. Statistical Methods for Rates and Proportions, 2nd ed , 1981 .
[7] J. Hirsh,et al. Relationship between the anticoagulant and antithrombotic effects of heparin in experimental venous thrombosis. , 1977, Blood.
[8] C. Dollery,et al. Heparin Kinetics in Venous Thrombosis and Pulmonary Embolism , 1976, Circulation.
[9] E W Salzman,et al. Management of heparin therapy: Controlled prospective trial. , 1975, The New England journal of medicine.
[10] J. Fleiss,et al. Statistical methods for rates and proportions , 1973 .
[11] J. Hirsh,et al. A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. , 1972, The New England journal of medicine.
[12] N. Mantel. Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.
[13] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .